EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII(+) glioblastoma xenografts

Receptor tyrosine kinase (RTK) systems, such as hepatocyte growth factor (HGF) and its receptor c-Met, and EGFR, are responsible for the malignant progression of multiple solid tumors. Recent research shows that these RTK systems co-modulate overlapping and dynamically adaptable oncogenic downstream...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lal, Bachchu, Goodwin, Courtney R., Sang, Yingying, Foss, Catherine A., Cornet, Kathrine, Muzamil, Sameena, Pomper, Martin G., Kim, Jin, Laterra, John
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2846399/
https://ncbi.nlm.nih.gov/pubmed/19584231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-09-0188
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados